Isospec Analytics
Isospec Analytics is redefining the limits of molecular analysis with its AI-enhanced IR fingerprinting technology. This technology identifies new molecules in minutes instead of weeks, offering a new dimension of chemical and biological understanding. Their mission is to transform healthcare outcomes by pioneering molecular technologies that unlock new frontiers in disease understanding and treatment, focusing on biomarker discovery, therapeutic development, and clinical nutrition. The company has completed 18 projects, discovered 20 molecules, and serves customers in 12 countries. Key team members include Ahmed Ben Faleh (Co-founder, CEO), Stephan Warnke (CTO), and Thomas Rizzo (CSO).
Isospec Analytics
Isospec Analytics is redefining the limits of molecular analysis with its AI-enhanced IR fingerprinting technology. This technology identifies new molecules in minutes instead of weeks, offering a new dimension of chemical and biological understanding. Their mission is to transform healthcare outcomes by pioneering molecular technologies that unlock new frontiers in disease understanding and treatment, focusing on biomarker discovery, therapeutic development, and clinical nutrition. The company has completed 18 projects, discovered 20 molecules, and serves customers in 12 countries. Key team members include Ahmed Ben Faleh (Co-founder, CEO), Stephan Warnke (CTO), and Thomas Rizzo (CSO).
